about
A case report of Merkel cell carcinoma on chronic lymphocytic leukemia: differential diagnosis of coexisting lymphadenopathy and indications for early aggressive treatment.Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family.Molecular detection of the G(-248)A BAX promoter nucleotide change in B cell chronic lymphocytic leukaemiaThe histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cellsATM mutations in sporadic lymphoid tumours.Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.Monocyte-derived dendritic cells in chronic lymphocytic leukemia.Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATPPotential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules.Microenvironmental interactions and survival of CLL B-cells.Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells.Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes.CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.Inflammation and survival pathways: chronic lymphocytic leukemia as a model system.Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells.Flow cytometric detection of total and serine 473 phosphorylated Akt.Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells.Bisindolylmaleimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1.AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway.Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia.Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemiaIs there a role for the platelet-to-lymphocyte ratio in chronic lymphocytic leukemia?
P2860
Q24813099-21800132-51B0-4B22-AE34-1063631BF755Q30971455-99B96F2A-904B-481C-8B55-54E45174CDC2Q33919200-21ECB6D9-B330-41D8-BDA7-4D515E87AADAQ33952785-4446164A-0CFE-4A9F-866E-6E3A337D7110Q34980360-C6AB4272-9A77-4ECC-8F78-F30AE3DA65AFQ35104347-8E58E50C-E7F4-438A-9CC7-6C608E407DA0Q35210402-38BD75A0-C72A-452D-B183-35EB1363562BQ35847611-5179AFEA-1A60-41C2-9BF1-0993AA7A25B3Q35847648-51FB6E6E-65E1-40B2-BD4F-0C00496D115AQ35994836-EF7FA4FE-74C7-4ADD-A5BE-E2FD83DF6BA4Q36194575-881CC527-C8B2-4942-924A-B75C4E4C0362Q36825701-B9FA1A6D-085F-41F5-AE82-835B55B0C70AQ36981741-6DD5EBA6-CD2C-49A7-BC87-6132EB129FFEQ37625487-35C3C165-C1D5-4B7A-A7A6-FC18FDE2BDC8Q37778876-10AC9C74-0767-4A0E-AB7D-8B0357D3550DQ39783008-2CF29A70-DB2C-4484-8320-F8D0E18254F3Q40549559-565C0140-772E-4656-B879-790615FE5A83Q40605691-8A107614-D7E5-42DD-A1BE-99C72970E628Q40636307-1583ADCA-E570-4ED3-9440-D90429078AD2Q42115123-06AE6F2B-02BC-400B-907C-B215EA55149DQ44429639-923886B9-F77C-4E6D-B164-9F29F85935C9Q44598662-A409C8D9-0912-4E41-876E-C078FD18E04FQ45296438-164A5FF1-4EDB-468B-9222-3CBDD54F548AQ46902748-98500433-1901-461F-B8DB-765927061030Q54584717-F3F3A5BD-54A9-484A-97E3-CA5161F245C2Q54698123-3392C1EE-B267-460F-B9B9-C8CFEDAB05C0Q58484362-0B85F4C5-6D79-43BA-933B-0F3FFEBCB789Q59131899-00043F3C-ABFE-4482-B6F6-54DEFB488FCE
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Update on the biology of chronic lymphocytic leukemia.
@ast
Update on the biology of chronic lymphocytic leukemia.
@en
type
label
Update on the biology of chronic lymphocytic leukemia.
@ast
Update on the biology of chronic lymphocytic leukemia.
@en
prefLabel
Update on the biology of chronic lymphocytic leukemia.
@ast
Update on the biology of chronic lymphocytic leukemia.
@en
P1476
Update on the biology of chronic lymphocytic leukemia.
@en
P2093
P356
10.1097/00001622-200001000-00004
P577
2000-01-01T00:00:00Z